Accueil › Cancer du poumon non à petites cellules › Caroline du Nord › Durham
Essais cliniques pour Cancer du poumon non à petites cellules à Durham, NC
39 études pour Cancer du poumon non à petites cellules recherchent des participants dans et autour de Durham (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- Duke University Medical Center, Durham
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Recrutement en coursPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Duke University, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Recrutement en coursPhase 1
- Exelixis Clinical Site #12, Durham
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Recrutement en coursPhase 3
- UNC Lineberger Comprehensive Cancer Center ( Site 3250), Chapel Hill · à 10 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Recrutement en coursPhase 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Recrutement en coursPhase 3
- Duke Cancer Center, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- PHN-012-001 Site, Durham
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recrutement en coursPhase 3
- UNC Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · à 10 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Recrutement en coursPhase 3
- Duke University Medical Center, Durham
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 2
- University of North Carolina at Chapel Hill, Chapel Hill · à 10 mi
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Recrutement en coursPhase 1/2
- Duke Cancer Center Durham, Durham
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Recrutement en coursPhase 3
- Clinical Study Site, Durham
- Clinical Study Site, Chapel Hill · à 10 mi
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Recrutement en coursPhase 3
- Durham VA Health Care System, Durham
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Recrutement en coursPhase 1/2
- Duke University School of Medicine, Durham
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Recrutement en coursPhase 2/3
- Duke University Medical Center, Durham
Effects of Infusion Timing on Treatment Response in Solid Tumors
Recrutement en coursPhase 2
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · à 10 mi
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recrutement en coursÉtude observationnelle
- UNC- Chapel Hill, Chapel Hill · à 10 mi
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Recrutement en coursPhase 1
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · à 10 mi
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Recrutement en coursPhase 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · à 10 mi
- University of North Carolina, Chapel Hill · à 10 mi
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Recrutement en coursPhase 1/2
- Duke Cancer Institute, Durham
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Recrutement en coursPhase 2
- UNC Health - University of North Carolina, Chapel Hill · à 10 mi
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Recrutement en coursPhase 1
- Duke University Medical Center, Durham
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Recrutement en coursPhase 1/2
- Duke Cancer Institute, Durham
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Duke Cancer Center, Durham
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recrutement en coursPhase 2
- University of North Carolina, Chapel Hill · à 10 mi
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Recrutement en coursPhase 1
- Duke Cancer Institute /ID# 276267, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Recrutement en coursPhase 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Recrutement en coursPhase 1
- Duke Cancer Center /ID# 251975, Durham
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Durham VA Medical Center, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Recrutement en coursPhase 1
- Duke Cancer Center, Durham
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Durham VA Medical Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Recrutement en cours
- Durham VA Medical Center, Durham, NC, Durham
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
Recrutement en coursPhase 1 précoce
- Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
GEMINI-NSCLC: NSCLC Biomarker Study
Recrutement en coursÉtude observationnelle
- Duke University, Durham
- UNC, Chapel Hill · à 10 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Chapel Hill · à 10 mi
A Study of NX-1607 in Adults With Advanced Malignancies
Recrutement en coursPhase 1
- University of North Carolina, Chapel Hill · à 10 mi
Essais pour Cancer du poumon non à petites cellules dans d'autres villes
- Houston, TX145 études
- New York City, NY121 études
- Arlington, VA104 études
- Nashville, TN97 études
- Boston, MA90 études
- Los Angeles, CA87 études
- St. Louis, MO73 études
- Chicago, IL61 études
- Baltimore, MD60 études
- San Antonio, TX59 études
- Columbus, OH57 études
- Washington, DC55 études
Autres études à Durham
- Cancer du sein64 études
- Cancer (tous types)58 études
- Myélome multiple37 études
- Leucémie aiguë myéloïde33 études
- Cancer métastatique33 études
- Cancer de la prostate32 études
- Cancer du poumon32 études
- Cancer colorectal28 études
- Cancer de l'ovaire27 études
- Leucémie lymphocytaire chronique27 études
- Insuffisance cardiaque26 études
- Cancer du pancréas24 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.